Clinical Trial

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

Study acronym: EMPOWER-D-Afg
Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
Trial Details
NCT Number NCT07350694
Lead Sponsor HealthNet Transcultural Psychosocial Organization
Collaborators: University of York, Khyber Medical University Peshawar, National Institute for Health Research, United Kingdom, Aga Khan University
Conditions Diabetes Type 2, Type II Diabetes Mellitus
Enrollment 250 participants
Start Date 2024-12-24
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-20